<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab1" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Experimental studies of natural cinnamaldehyde and its derivation on neurological diseases.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="1" colspan="1">Natural cinnamaldehyde derivation</th>
    <th align="center" rowspan="1" colspan="1">Model</th>
    <th align="center" rowspan="1" colspan="1">Animal/cell</th>
    <th align="center" rowspan="1" colspan="1">Effective dose</th>
    <th align="center" rowspan="1" colspan="1">Mechanism</th>
    <th align="center" rowspan="1" colspan="1">Result</th>
    <th align="center" rowspan="1" colspan="1">Main effect</th>
    <th align="left" rowspan="1" colspan="1">Ref.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">CA</td>
    <td align="center" rowspan="1" colspan="1">Permanent cerebral ischemia</td>
    <td align="center" rowspan="1" colspan="1">Mouse</td>
    <td align="center" rowspan="1" colspan="1">50 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">Suppress the activation of TLR4, TRAF6, and NF-
     <italic>κ</italic>B signaling
    </td>
    <td align="center" rowspan="1" colspan="1">Attenuate levels of TNF-
     <italic>α</italic>, IL-1
     <italic>β</italic>, CCL2, and ELAM-1
    </td>
    <td align="center" rowspan="1" colspan="1">Anti-inflammatory effect</td>
    <td align="left" rowspan="1" colspan="1">[
     <xref rid="B31" ref-type="bibr">31</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">CA</td>
    <td align="center" rowspan="1" colspan="1">Glutamate toxicity</td>
    <td align="center" rowspan="1" colspan="1">PC12 cells</td>
    <td align="center" rowspan="1" colspan="1">20 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibit intracellular ROS accumulation, increase Bcl-2 expression, inhibit Bax expression, block the release of cytochrome c, and decrease the LC3-II/LC3-I ratio</td>
    <td align="center" rowspan="1" colspan="1">Maintain normal mitochondrial membrane potential and prevent the activation of autophagy</td>
    <td align="center" rowspan="1" colspan="1">Antioxidative stress and antiapoptotic effects</td>
    <td align="left" rowspan="1" colspan="1">[
     <xref rid="B17" ref-type="bibr">17</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">CA</td>
    <td align="center" rowspan="1" colspan="1">Diabetic neuropathy</td>
    <td align="center" rowspan="1" colspan="1">DRG</td>
    <td align="center" rowspan="1" colspan="1">100 nmol/L</td>
    <td align="center" rowspan="1" colspan="1">Inhibits the activation of NF-
     <italic>κ</italic>B pathway
    </td>
    <td align="center" rowspan="1" colspan="1">Attenuate caspase-3 activation and downregulate IL-6, TNF-
     <italic>α</italic>, COX, and iNOS levels
    </td>
    <td align="center" rowspan="1" colspan="1">Anti-inflammatory effect</td>
    <td align="left" rowspan="1" colspan="1">[
     <xref rid="B34" ref-type="bibr">34</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">CA</td>
    <td align="center" rowspan="1" colspan="1">Sciatic nerve crush</td>
    <td align="center" rowspan="1" colspan="1">Rat</td>
    <td align="center" rowspan="1" colspan="1">30 mg/kg/day</td>
    <td align="center" rowspan="1" colspan="1">Upregulate the number of regenerated nerves and Schwann cells</td>
    <td align="center" rowspan="1" colspan="1">Promote nerve regeneration, motor function recovery, and muscle mass</td>
    <td align="center" rowspan="1" colspan="1">Neuroprotective effect</td>
    <td align="left" rowspan="1" colspan="1">[
     <xref rid="B38" ref-type="bibr">38</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">TCA</td>
    <td align="center" rowspan="1" colspan="1">Depression</td>
    <td align="center" rowspan="1" colspan="1">Mouse</td>
    <td align="center" rowspan="1" colspan="1">50 mg/kg</td>
    <td align="center" rowspan="1" colspan="1">−</td>
    <td align="center" rowspan="1" colspan="1">Regulate the level of GABA neurotransmitter and also regulate the eCB system by downregulation of TRPV1 and CB1</td>
    <td align="center" rowspan="1" colspan="1">Antidepressive effect</td>
    <td align="left" rowspan="1" colspan="1">[
     <xref rid="B39" ref-type="bibr">39</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">HCA</td>
    <td align="center" rowspan="1" colspan="1">LPS-induced neuroinflammation</td>
    <td align="center" rowspan="1" colspan="1">BV-2 microglial cells</td>
    <td align="center" rowspan="1" colspan="1">2 
     <italic>μ</italic>M
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibit ERK, JNK, p38 MAPK, and NF-
     <italic>κ</italic>B activation by target LRP1 and reduce microglia-mediated neuroblastoma cell death
    </td>
    <td align="center" rowspan="1" colspan="1">Attenuate the expression of iNOS and proinflammatory cytokines such as IL-1
     <italic>β</italic> and TNF-
     <italic>α</italic>
    </td>
    <td align="center" rowspan="1" colspan="1">Anti-inflammatory and neuroprotective effects</td>
    <td align="left" rowspan="1" colspan="1">[
     <xref rid="B19" ref-type="bibr">19</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn>
   <p>Abbreviations: HCA: 2-hydroxycinnamaldehyde; MCA: 2-methoxycinnamaldehyde; DRG: dorsal root ganglion neurons; LPS: lipopolysaccharide; TRAF6: tumor necrosis receptor-associated factor 6; TLR4: Toll-like receptor 4; eCB: endocannabinoid; MAPKs: mitogen-activated protein kinases, ERK: extracellular-regulated kinase; JNK: c-Jun N-terminal kinase; COX: cyclooxygenase; iNOS: inducible nitric oxide synthase; NO: nitric oxide; IL-1
    <italic>β</italic>: interleukin-1
    <italic>β</italic>; IL-6: interleukin-6; TNF-
    <italic>α</italic>: tumor necrosis factor-
    <italic>α</italic>; NF-
    <italic>κ</italic>B: nuclear factor kappa B; TRPA1: transient receptor potential ankyrin 1; ROS: reactive oxygen species; MDA: malondialdehyde; Bcl-2: B cell lymphoma 2; BAX: BCL2-Associated X; CCL2: C-C Motif Chemokine Ligand 2; ELAM-1: endothelial-leukocyte adhesion molecule 1; GABA: Gamma-Aminobutyric acid; TRPV1: transient receptor potential cation channel subfamily V member 1; LRP1: low-density lipoprotein receptor-related protein 1; LC3: microtubule-associated protein light chain 3.
   </p>
  </fn>
 </table-wrap-foot>
</table-wrap>
